Skip to main content

Table 1

From: Structural and functional characterisation of new-onset idiopathic dilated cardiomyopathy, and its response to therapy

Parameter Baseline Follow-up P-value
CMR    
LV ejection fraction ± SD (%) 27 ± 9 45 ± 10 <0.001
LV end-systolic volume ± SD (mL) 120 ± 42 93 ± 46 0.004
LV end-diastolic volume ± SD (mL) 167 ± 45 155 ± 53 0.1
LV mass ± SD (g) 158 ± 39 147 ± 34 0.004
LV eccentricity index (LV mass/LVEDV) ± SD (g/mL) 0.64 ± 0.13 0.76 ± 0.17 0.03
RV ejection fraction ± SD (%) 46 ± 15 60 ± 9 0.004
RV end-diastolic volume ± SD (mL) 79 ± 38 60 ± 32 0.2
RV end-systolic volume ± SD (mL) 143 ± 42 140 ± 47 0.4
Echocardiographic    
LA volume ± SD (mL) 97 ± 30 73 ± 26 0.002
LA strain ± SD (%) 12 ± 6 19 ± 6 0.02
E/A ratio 1.4 ± 0.9 0.9 ± 0.4 0.04
Diastolic grade ± SD 2.4 ± 1.1 1.3 ± 0.8 0.002
Functional    
Heart rate ± SD (bpm) 80 ± 17 64 ± 13 <0.001
6-MWD ± SD (m) 421 ± 103 483 ± 85 0.07
VO2 MAX ± SD (mL/kg/min) 20 ± 5 21 ± 5 0.7
MLWHF score 40 ± 19 30 ± 21 0.13